REQUEST A DEMO
Total
USD $0.00
Search more companies

Endocrinologos del Oriente S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Endocrinologos del Oriente S.A.S. Profile Updated: April 08, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Endocrinologos del Oriente S.A.S. is based in Colombia, with the head office in Floridablanca. The enterprise operates in the Ambulatory Health Care Services industry. The enterprise was incorporated on December 28, 2010. It currently has a total number of 2 (2026) employees. The latest financial highlights indicate a net sales revenue increase of 13.53% in 2025. A growth of 2.88% was recorded in its total assets. The net profit margin of Endocrinologos del Oriente S.A.S. increased by 9.15% in 2025.

Headquarters
Calle 158 # 20 - 95 Piso 4 Consultorio C 408
Floridablanca; Santander;

Contact Details: Purchase the Endocrinologos del Oriente S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Endocrinologos del Oriente S.A.S. report to view the information.
Registered Capital:
Purchase the Endocrinologos del Oriente S.A.S. report to view the information.
Financial Auditors:
Purchase the Endocrinologos del Oriente S.A.S. report to view the information.
Incorporation Date:
December 28, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Endocrinologos del Oriente S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
13.53%
Total Operating Revenue
13.53%
Net Profit/Loss for the Period
240.11%
Total Assets
2.88%
Total Equity
41.47%
Net Profit Margin
9.15%
Return on Equity (ROE)
20.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?